About biotechnology application, Biotech Summit Advisory Board

Sports / Entertainment



Trinity Biotech Announces Distribution Agreement for Premier Hb9210 Instrument With Menarini Diagnostics 0

Posted on February 19, 2011 by admin

Trinity Biotech Announces Distribution Agreement for Premier Hb9210 Instrument With Menarini Diagnostics
DUBLIN, IRELAND–(Marketwire – 02/15/11) – Trinity Biotech plc (NASDAQ: TRIB – News ), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced an agreement to exclusively supply Menarini Diagnostics with the new Premier Hb9210 (PDx) instrument for distribution in European territories. The Premier Hb9210 instrument is a …

Read more on Marketwire via Yahoo! Finance

Big demand for biotech company 0

Posted on February 18, 2011 by admin

Big demand for biotech company
Growing international demand for biotech company Canterbury Scientific’s products has prompted it to invest $1.2 million in new research and development facilities in Addington.

Read more on Stuff

What is the Biotech Academy? 0

Posted on February 15, 2011 by admin


The Biotechnology Magnet Academy at Southwood High School is a free, four-year freshman-to-senior program that challenges students through a rigorous college-preparatory math and science curriculum, which prepares them to earn advanced degrees in science or medicine. Middle school students recently completed a series of science experiments at Sci-Port, Louisiana’s Science Center, in Shreveport, LA. While having fun and learning about science, students were introduced to the Biotech Magnet Academy. To learn more visit: www.cpsb-mst.com

Louisville biotech firm’s drug could improve a broodmare’s chance of pregnancy on the first date 0

Posted on February 13, 2011 by admin

Louisville biotech firm’s drug could improve a broodmare’s chance of pregnancy on the first date
At Valentine’s Day, the Thoroughbred industry’s thoughts turn to the breeding shed, where

Read more on Lexington Herald-Leader

Battle of the Bulge: Biotech Takes on Obesity and Diabetes 0

Posted on February 11, 2011 by admin

Battle of the Bulge: Biotech Takes on Obesity and Diabetes
Will recent advances in pharmaceutical research revolutionize the weight loss industry?

Read more on The Motley Fool

Biotech Stocks: Mannkind pressures drug stocks 0

Posted on February 11, 2011 by admin

Biotech Stocks: Mannkind pressures drug stocks
Shares of Mannkind Corp. sank 20% on news that it was laying off 41% of its workforce in order to focus its resources on its troubled inhaled insulin product Afrezza.

Read more on Market Watch

ML biotech leaders give Melmark $365,000 0

Posted on February 06, 2011 by admin

ML biotech leaders give Melmark $365,000
Leaders of the Main Line life-sciences and business communities presented Melmark with a check for $365,000. The money, raised during the Fifth Annual Hubert J.P. Schoemaker Classic with Cephalon serving as the title sponsor and Accenture and Oracle Health Sciences the co-presenting sponsors, will help Melmark, a nonprofit organization in Berwyn, in its mission of supporting children and adults …

Read more on Main Line Suburban Life

14 Years of Biotech Agriculture 0

Posted on February 06, 2011 by admin


A short video “14 years of Biotech Agriculture” is an information capsule on the commercialization of biotech crops between 1996 to 2009. In the biotech capsule, Dr. Clive James summaries the impact of 14 years of biotech agriculture in which millions of farmers benefited significantly by growing millions of acres of biotech crops in both developing and industrial countries around the world. The capsule also highlights impact of Bt cotton in India, Bt maize in the Philippines, Biotech crops in Africa and future prospects of biotech crops in agriculture including golden rice.

Marina Biotech and The Debiopharm Group Partner to Develop and Commercialize RNAi-Based Therapies for the Treatment of … 0

Posted on February 05, 2011 by admin

Marina Biotech and The Debiopharm Group Partner to Develop and Commercialize RNAi-Based Therapies for the Treatment of …
LAUSANNE, SWITZERLAND and BOTHELL, WA–(Marketwire – 02/03/11) – The Debiopharm Group (Debiopharm), a global independent biopharmaceutical development group of companies with a main focus in oncology and serious medical conditions, and Marina Biotech, Inc. (NASDAQ: MRNA – News ), a leading RNAi-based drug discovery and development company, announced today that they entered into an exclusive …

Read more on Marketwire via Yahoo! Finance

QIAGEN (Biotech Company) Hiring NBC Washington Jobs 4 You 0

Posted on February 05, 2011 by admin


This spot appeared on NBC Washington during the Jobs 4 You segment.



↑ Top

Powered by Yahoo! Answers